Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone Augmentation for Refractory Social Anxiety Disorder
NCT00215150Phase 2Completed
- Sponsor
- Duke University
- Start
- Nov 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ziprasidone in Social Anxiety Disorder (SAD), sponsored by Duke University. Started Nov 2004; status: completed.
02
Drugs
ziprasidone
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00215150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215150.